Prospective Cohort of Patients With Intracerebral Hemorrhage
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- De-zhi Kang, MD
First Affiliated Hospital of Fujian Medical University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Recruiting - Anxi County Hospital
Quanzhou, Fujian, China
Recruiting - Jinjiang Municipal Hospital
Quanzhou, Fujian, China
Recruiting - the Second Affiliated Lospital of Xiamen Medical College
Xiamen, Fujian, China
Recruiting - Zhangzhou Municipal Hospital
Zhangzhou, Fujian, China
Recruiting - Liaocheng People'S Hospital
Liaocheng, Shandong, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Nov 2023
- Primary completion
- 31 Dec 2027
- Completion
- 30 Dec 2028
- Last update posted
- 1 Nov 2024
- Registered enrollment
- 3,000
- Registry id
- NCT06670456
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.